Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV002475126 | SCV002771372 | likely pathogenic | not provided | 2021-07-30 | criteria provided, single submitter | clinical testing | This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). |
Labcorp Genetics |
RCV002574704 | SCV003485162 | pathogenic | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2024-09-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg4693*) in the SYNE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SYNE1 are known to be pathogenic (PMID: 19542096, 24319099, 27086870). This variant is present in population databases (rs769419654, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1807169). For these reasons, this variant has been classified as Pathogenic. |
Mayo Clinic Laboratories, |
RCV002475126 | SCV005413760 | likely pathogenic | not provided | 2024-09-16 | criteria provided, single submitter | clinical testing | PM2, PVS1 |